Healthcare • Biotechnology
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BLTE is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
28 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 9 days ago
Red flags: 0
81 filers reported a long position in BLTE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Darwin Global Management, Ltd. | $456.6M | 3.1M | +0.6% |
| Paradigm Biocapital Advisors LP | $189.8M | 1.2M | +10.6% |
| RTW INVESTMENTS, LP | $110.2M | 715.3K | Unchanged |
| MILLENNIUM MANAGEMENT LLC | $76.2M | 494.6K | -13.2% |
| MAVERICK CAPITAL LTD | $61M | 396.3K | New |
| EVENTIDE ASSET MANAGEMENT, LLC | $60.2M | 390.8K | +9.3% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $55M | 357.2K | +17.5% |
| Holocene Advisors, LP | $38.7M | 251K | -49.2% |
| Logos Global Management LP | $38.5M | 250K | New |
| MORGAN STANLEY | $36.2M | 235.1K | +16.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.